This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Alfred Notowicz, MD; Ernst Stolz, MD; Nellie v. d. Heuvel, MD
Rotterdam, Netherlands

Arch Dermatol. 1978;114(1):129.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The therapy for Hallopeau's acrodermatitis (continua, perstans), which includes the use of common topical antipsoriatic agents like tar, cignolin, and corticosteroids, is mentioned in literature, but the extreme resistance of the disease to any therapy is well known.

The systemic use of cytostatic agents (methotrexate) has been described with good results in this disease, but it carries all the inevitable risks of a long-term treatment.¹ Topical use of methotrexate soaks under occlusion, which have been used alternately with betamethasone valerate, has been found to have beneficial results in the treatment of relapsing pustular eruption of the hands and feet.²

We could not find a report of the topical use of a cytostatic agent in the treatment of Hallopeau's acrodermatitis. Topical application of mechlorethamine hydrochloride (a nitrogen mustard) has been found to be useful in psoriasis.³ We decided to treat a patient with Hallopeau's acrodermatitis with . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?